# Study of [177Lu]Lu-PSMA-137 In Metastatic Castrate Resistant Prostate Cancer（mCRPC）

> **NCT06546527** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Peking University First Hospital** · enrollment: 12 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** [177Lu]Lu-PSMA-137

## Key facts

- **NCT ID:** NCT06546527
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-08-01
- **Primary completion:** 2025-03-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2024-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06546527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06546527, "Study of [177Lu]Lu-PSMA-137 In Metastatic Castrate Resistant Prostate Cancer（mCRPC）". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT06546527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*